Global CRISPR and CRISPR-Associated (Cas) Genes Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of CRISPR and CRISPR-Associated (Cas) Genes will have significant change from previous year. According to our latest study, the global CRISPR and CRISPR-Associated (Cas) Genes market size is USD million in 2022 from USD 1354.3 million in 2021, with a change of % between 2021 and 2022. The global CRISPR and CRISPR-Associated (Cas) Genes market size will reach USD 10020 million in 2028, growing at a CAGR of 33.1% over the analysis period.
The United States CRISPR and CRISPR-Associated (Cas) Genes market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global CRISPR and CRISPR-Associated (Cas) Genes market, reaching US$ million by the year 2028. As for the Europe CRISPR and CRISPR-Associated (Cas) Genes landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main CRISPR and CRISPR-Associated (Cas) Genes players cover Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, and CRISPR therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of CRISPR and CRISPR-Associated (Cas) Genes market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Genome Editing
Genetic engineering
gRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size 2017-2028
2.1.2 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 CRISPR and CRISPR-Associated (Cas) Genes Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic engineering
2.2.3 gRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type
2.3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2022)
2.4 CRISPR and CRISPR-Associated (Cas) Genes Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application
2.5.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2022)
3 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Player
3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Players
3.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2020-2022)
3.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Players (2020-2022)
3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR and CRISPR-Associated (Cas) Genes by Regions
4.1 CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions (2017-2022)
4.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2017-2022)
4.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2017-2022)
4.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2017-2022)
4.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth (2017-2022)
5 Americas
5.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022)
5.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
5.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022)
6.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
6.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR and CRISPR-Associated (Cas) Genes by Country (2017-2022)
7.2 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
7.3 Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes by Region (2017-2022)
8.2 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022)
8.3 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Regions (2023-2028)
10.1.1 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Regions (2023-2028)
10.1.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.1.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Forecast
10.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Forecast by Country (2023-2028)
10.2.1 United States CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.2.2 Canada CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.2.3 Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.2.4 Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2023-2028)
10.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.2 Japan CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.3 Korea CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.4 Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.5 India CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.3.6 Australia CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.4 Europe CRISPR and CRISPR-Associated (Cas) Genes Forecast by Country (2023-2028)
10.4.1 Germany CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.4.2 France CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.4.3 UK CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.4.4 Italy CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.4.5 Russia CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.5 Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Forecast by Region (2023-2028)
10.5.1 Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.5.2 South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.5.3 Israel CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.5.4 Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.5.5 GCC Countries CRISPR and CRISPR-Associated (Cas) Genes Market Forecast
10.6 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Type (2023-2028)
10.7 Global CRISPR and CRISPR-Associated (Cas) Genes Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Information
11.2.2 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Editas Medicine Main Business Overview
11.2.5 Editas Medicine Latest Developments
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Information
11.3.2 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Caribou Biosciences Main Business Overview
11.3.5 Caribou Biosciences Latest Developments
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Information
11.4.2 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 CRISPR therapeutics Main Business Overview
11.4.5 CRISPR therapeutics Latest Developments
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Information
11.5.2 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Intellia therapeutics, Inc. Main Business Overview
11.5.5 Intellia therapeutics, Inc. Latest Developments
11.6 Cellectis
11.6.1 Cellectis Company Information
11.6.2 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Cellectis Main Business Overview
11.6.5 Cellectis Latest Developments
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Information
11.7.2 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Horizon Discovery Plc Main Business Overview
11.7.5 Horizon Discovery Plc Latest Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Information
11.8.2 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sigma Aldrich Main Business Overview
11.8.5 Sigma Aldrich Latest Developments
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Information
11.9.2 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Precision Biosciences Main Business Overview
11.9.5 Precision Biosciences Latest Developments
11.10 Genscript
11.10.1 Genscript Company Information
11.10.2 Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Genscript Main Business Overview
11.10.5 Genscript Latest Developments
11. Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Information
11.11.2 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Sangamo Biosciences Inc. Main Business Overview
11.11.5 Sangamo Biosciences Inc. Latest Developments
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Information
11.12.2 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Lonza Group Limited Main Business Overview
11.12.5 Lonza Group Limited Latest Developments
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Information
11.13.2 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Integrated DNA Technologies Main Business Overview
11.13.5 Integrated DNA Technologies Latest Developments
11.14 New England Biolabs
11.14.1 New England Biolabs Company Information
11.14.2 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 New England Biolabs Main Business Overview
11.14.5 New England Biolabs Latest Developments
11.15 Origene Technologies
11.15.1 Origene Technologies Company Information
11.15.2 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
11.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Origene Technologies Main Business Overview
11.15.5 Origene Technologies Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Genome Editing
Table 3. Major Players of Genetic engineering
Table 4. Major Players of gRNA Database/Gene Librar
Table 5. Major Players of CRISPR Plasmid
Table 6. Major Players of Human Stem Cells
Table 7. Major Players of Genetically Modified Organisms/Crops
Table 8. Major Players of Cell Line Engineering
Table 9. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2022)
Table 12. CRISPR and CRISPR-Associated (Cas) Genes Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2022)
Table 15. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player (2020-2022)
Table 17. CRISPR and CRISPR-Associated (Cas) Genes Key Players Head office and Products Offered
Table 18. CRISPR and CRISPR-Associated (Cas) Genes Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Regions (2017-2022)
Table 23. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country (2017-2022)
Table 25. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2022)
Table 27. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2022)
Table 29. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2017-2022)
Table 31. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2022)
Table 33. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2022)
Table 35. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country (2017-2022)
Table 37. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2022)
Table 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of CRISPR and CRISPR-Associated (Cas) Genes
Table 48. Key Market Challenges & Risks of CRISPR and CRISPR-Associated (Cas) Genes
Table 49. Key Industry Trends of CRISPR and CRISPR-Associated (Cas) Genes
Table 50. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share Forecast by Application (2023-2028)
Table 56. Thermo Fisher Scientific Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 57. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 58. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Thermo Fisher Scientific Main Business
Table 60. Thermo Fisher Scientific Latest Developments
Table 61. Editas Medicine Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 62. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 63. Editas Medicine Main Business
Table 64. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Editas Medicine Latest Developments
Table 66. Caribou Biosciences Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 67. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 68. Caribou Biosciences Main Business
Table 69. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Caribou Biosciences Latest Developments
Table 71. CRISPR therapeutics Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 72. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 73. CRISPR therapeutics Main Business
Table 74. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. CRISPR therapeutics Latest Developments
Table 76. Intellia therapeutics, Inc. Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 77. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 78. Intellia therapeutics, Inc. Main Business
Table 79. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Intellia therapeutics, Inc. Latest Developments
Table 81. Cellectis Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 82. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 83. Cellectis Main Business
Table 84. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Cellectis Latest Developments
Table 86. Horizon Discovery Plc Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 87. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 88. Horizon Discovery Plc Main Business
Table 89. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Horizon Discovery Plc Latest Developments
Table 91. Sigma Aldrich Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 92. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 93. Sigma Aldrich Main Business
Table 94. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Sigma Aldrich Latest Developments
Table 96. Precision Biosciences Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 97. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 98. Precision Biosciences Main Business
Table 99. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Precision Biosciences Latest Developments
Table 101. Genscript Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 102. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 103. Genscript Main Business
Table 104. Genscript CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Genscript Latest Developments
Table 106. Sangamo Biosciences Inc. Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 107. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 108. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Sangamo Biosciences Inc. Main Business
Table 110. Sangamo Biosciences Inc. Latest Developments
Table 111. Lonza Group Limited Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 112. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 113. Lonza Group Limited Main Business
Table 114. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Lonza Group Limited Latest Developments
Table 116. Integrated DNA Technologies Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 117. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 118. Integrated DNA Technologies Main Business
Table 119. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Integrated DNA Technologies Latest Developments
Table 121. New England Biolabs Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 122. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 123. New England Biolabs Main Business
Table 124. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. New England Biolabs Latest Developments
Table 126. Origene Technologies Details, Company Type, CRISPR and CRISPR-Associated (Cas) Genes Area Served and Its Competitors
Table 127. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product Offered
Table 128. Origene Technologies Main Business
Table 129. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Origene Technologies Latest Developments
List of Figures
Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type in 2021
Figure 7. CRISPR and CRISPR-Associated (Cas) Genes in Biotechnology Companies
Figure 8. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Biotechnology Companies (2017-2022) & ($ Millions)
Figure 9. CRISPR and CRISPR-Associated (Cas) Genes in Pharmaceutical Companies
Figure 10. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Pharmaceutical Companies (2017-2022) & ($ Millions)
Figure 11. CRISPR and CRISPR-Associated (Cas) Genes in Academic Institutes
Figure 12. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Academic Institutes (2017-2022) & ($ Millions)
Figure 13. CRISPR and CRISPR-Associated (Cas) Genes in Research and Development Institutes
Figure 14. Global CRISPR and CRISPR-Associated (Cas) Genes Market: Research and Development Institutes (2017-2022) & ($ Millions)
Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2021
Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Market Share by Player in 2021
Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Regions (2017-2022)
Figure 18. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size 2017-2022 ($ Millions)
Figure 19. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size 2017-2022 ($ Millions)
Figure 20. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2017-2022 ($ Millions)
Figure 22. Americas CRISPR and CRISPR-Associated (Cas) Genes Value Market Share by Country in 2021
Figure 23. Americas CRISPR and CRISPR-Associated (Cas) Genes Consumption Market Share by Type in 2021
Figure 24. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2021
Figure 25. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region in 2021
Figure 30. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2021
Figure 31. China CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 35. India CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Country in 2021
Figure 38. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type in 2021
Figure 39. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2021
Figure 40. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 41. France CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Application in 2021
Figure 48. Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 54. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 55. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 57. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 58. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 59. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 60. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 61. China CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 62. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 63. Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 65. India CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 66. Australia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 67. Germany CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 68. France CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 69. UK CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 70. Italy CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 71. Russia CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 72. Spain CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 73. Egypt CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 74. South Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 75. Israel CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 76. Turkey CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries CRISPR and CRISPR-Associated (Cas) Genes Market Size 2023-2028 ($ Millions)
